Pulmozyme--Dornase alfa.

C. Gutteridge, R. J. Kuhn

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Dornase alfa is the first new drug released in 30 years for the treatment of patients with CF. Although it does not represent a replacement for current standard therapies, it is an effective agent in improving lung function. The development of this drug has helped to provide treatment to a medical problem that physicians have struggled with treating for years.

Original languageEnglish
Pages (from-to)278-279
Number of pages2
JournalPediatric nursing
Issue number3
StatePublished - May 1994

ASJC Scopus subject areas

  • Pediatrics


Dive into the research topics of 'Pulmozyme--Dornase alfa.'. Together they form a unique fingerprint.

Cite this